EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review)

Xueqin Yang, Huarong Li, Hao Ye, Ting Wu, Fangyun Xu, Chao Hu, Chunlei Yu, Pian Ye

International Journal of Molecular Medicine · 05.08.2026 · 58 (4) · 1-32

DOI: 10.3892/ijmm.2026.5949 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 05.08.2026. Verfasst von Xueqin Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. C…. Hauptthemen laut MEDLINE: Liver Cirrhosis, p38 Mitogen-Activated Protein Kinases, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis is a progressive pathological state characterized by aberrant accumulation of extracellular matrix (ECM), predominantly mediated by activation of hepatic stellate cells (HSCs). If left untreated, this condition can progress to cirrhosis, liver failure, and even hepatocellular carcinoma. As a pivotal constituent of the mitogen‑activated protein kinase (MAPK) superfamily, p38 MAPK orchestrates critical cellular processes, including proliferation, differentiation, and stress responses. The p38 MAPK signaling cascade has been identified as a central orchestrator of the pathogenic mechanisms underlying liver fibrosis, mediating key processes such as HSC activation, ECM remodeling, inflammation, oxidative stress, and apoptosis. Developing novel antifibrotic therapies hinges on a comprehensive elucidation of the functional roles and regulatory mechanisms governing p38 MAPK. The present review aims to provide an exhaustive synthesis of the mechanisms and signaling networks by which p38 MAPK contributes to liver fibrogenesis. Its roles in HSC transformation, interactions with other critical pathways (including NF‑κB, TGF‑β/Smad, JAK/STAT, and PI3K/Akt), and involvement in inflammatory and oxidative responses are explored. Furthermore, the therapeutic potential of targeting p38 MAPK is highlighted by preclinical evidence from pharmacological inhibitors, natural compounds, and traditional medicines that modulate this pathway to attenuate fibrosis. In conclusion, while p38 MAPK represents a promising therapeutic target for liver fibrosis, future research should focus on developing isoform‑specific inhibitors, understanding context‑dependent signaling outcomes, and designing combination therapies to enhance efficacy and minimize off‑target effects. This synthesis aims to bridge current molecular insights with clinical translation, offering a roadmap for future antifibrotic drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Cirrhosisp38 Mitogen-Activated Protein KinasesSignal TransductionHumansAnimalsHepatic Stellate CellsMolecular Targeted Therapy

Stichwörter der Autor:innen

ECMHSCsliver fibrosismechanismsp38 MAPKsignaling pathwaystherapeutic targets

Substanzen

p38 Mitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
  • Department of Infectious Diseases, Jingshan Union Hospital, Union Hospital, Huazhong University of Science and Technology, Jingshan, Hubei 431899, P.R. China.

Zitieren

APA

Yang, X., Li, H., Ye, H., Wu, T., Xu, F., Hu, C., Yu, C., & Ye, P. (2026). Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review). International Journal of Molecular Medicine, 58(4), 1-32. https://doi.org/10.3892/ijmm.2026.5949

Vancouver

Yang X, Li H, Ye H, Wu T, Xu F, Hu C, et al. Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review). International Journal of Molecular Medicine. 2026;58(4):1-32. doi:10.3892/ijmm.2026.5949

BibTeX
@article{Yang2026,
  author = {Yang, Xueqin and Li, Huarong and Ye, Hao and Wu, Ting and Xu, Fangyun and Hu, Chao and Yu, Chunlei and Ye, Pian},
  title = {Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  volume = {58},
  number = {4},
  pages = {1--32},
  doi = {10.3892/ijmm.2026.5949}
}
Kostenlos starten →